U.S. Gastrointestinal Diagnostics Market Size & Outlook

The gastrointestinal diagnostics market in the United States is expected to reach a projected revenue of US$ 2,411.5 million by 2030. A compound annual growth rate of 3.8% is expected of the United States gastrointestinal diagnostics market from 2022 to 2030.
Revenue, 2021 (US$M)
$1,718.7
Forecast, 2030 (US$M)
$2,411.5
CAGR, 2022 - 2030
3.8%
Report Coverage
U.S.

U.S. gastrointestinal diagnostics market, 2018-2030 (US$M)

U.S.

U.S. gastrointestinal diagnostics market highlights

  • The U.S. gastrointestinal diagnostics market generated a revenue of USD 1,718.7 million in 2021 and is expected to reach USD 2,411.5 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 3.8% from 2022 to 2030.
  • In terms of segment, endoscopy was the largest revenue generating test type in 2021.
  • Blood test is the most lucrative test type segment registering the fastest growth during the forecast period.


Gastrointestinal diagnostics market data book summary

Market revenue in 2021USD 1,718.7 million
Market revenue in 2030USD 2,411.5 million
Growth rate3.8% (CAGR from 2021 to 2030)
Largest segmentEndoscopy
Fastest growing segmentBlood test
Historical data2018 - 2020
Base year2021
Forecast period2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationEndoscopy, Blood test, H. pylori test, Calprotectin test, Immunoglobulin A test
Key market players worldwideBioMerieux SA, Roche Holding AG, Abbott Laboratories, Beckman Coulter, Diasorin SpA, Siemens Healthineers AG ADR, Qiagen NV, Meridian Bioscience, Hologic Inc


Other key industry trends

  • In terms of revenue, U.S. accounted for 37.4% of the global gastrointestinal diagnostics market in 2021.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. gastrointestinal diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 231.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Gastrointestinal Diagnostics Market Scope

Gastrointestinal diagnostics market segmentation & scope
Endoscopy
Blood test
H. pylori test
Calprotectin test
Immunoglobulin A test
Others
ELISA
PCR
Microbiology
Others
Infection
Inflammatory Bowel Disease
Gastroesophageal Reflux Disease (GERD)
Cancer
Others
Central laboratories
Point-of-Care

Gastrointestinal Diagnostics Market Companies

Name Profile # Employees HQ Website

U.S. gastrointestinal diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gastrointestinal diagnostics market will help companies and investors design strategic landscapes.


Endoscopy was the largest segment with a revenue share of 28.75% in 2021. Horizon Databook has segmented the U.S. gastrointestinal diagnostics market based on endoscopy, blood test, h. pylori test, calprotectin test, immunoglobulin a test covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to U.S. gastrointestinal diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. gastrointestinal diagnostics market databook

  • Our clientele includes a mix of gastrointestinal diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. gastrointestinal diagnostics market, including forecasts for subscribers. This country databook contains high-level insights into U.S. gastrointestinal diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. gastrointestinal diagnostics market report size, by test type, 2018-2030 (US$M)

U.S. Gastrointestinal Diagnostics Market Share, 2021 & 2030 (US$M)

U.S. gastrointestinal diagnostics market report size, by test type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more